U.S. - Vaccines For Human Medicine - Market Analysis, Forecast, Size, Trends and Insights
Report Update: Apr 1, 2025

U.S. - Vaccines For Human Medicine - Market Analysis, Forecast, Size, Trends and Insights

Single report
Sent by email within 24h (Mon-Fri)
Subscription
Online access and download
from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Vaccines Prices in the United States

U.S. Vaccines Export Price in December 2021

In December 2021, the vaccines price stood at $2.1K per kg (FOB, US), declining by -13.7% against the previous month. Overall, the export price, however, showed a measured increase. The most prominent rate of growth was recorded in June 2021 an increase of 130% against the previous month. Over the period under review, the average export prices hit record highs at $3.9K per kg in September 2021; afterwards, it flattened through to December 2021.

Prices varied noticeably by the country of destination: the country with the highest price was the Philippines ($3.9K per kg), while the average price for exports to France ($206 per kg) was amongst the lowest.

From January 2021 to December 2021, the most notable rate of growth in terms of prices was recorded for supplies to Mexico (+62.2%), while the prices for the other major destinations experienced more modest paces of growth.

U.S. Vaccines Exports

In December 2021, vaccines exports from the United States surged to 1.2K tons, jumping by 50% against November 2021. Overall, exports posted significant growth. The growth pace was the most rapid in March 2021 when exports increased by 204% month-to-month. The exports peaked in December 2021.

In value terms, vaccines exports soared to $2.4B (IndexBox estimates) in December 2021. Over the period under review, exports recorded a significant expansion. The most prominent rate of growth was recorded in May 2021 with an increase of 352% month-to-month. Over the period under review, the exports attained the maximum at 2.9M tons in September 2021; however, from October 2021 to December 2021, the exports stood at a somewhat lower figure.

U.S. Vaccines Exports by Country

Brazil (184 tons), Belgium (108 tons) and Pakistan (106 tons) were the main destinations of vaccines exports from the United States, with a combined 34% share of total exports. Indonesia, Bangladesh, the Philippines, Mexico, Vietnam, Nigeria, the Netherlands, Peru, France and Chile lagged somewhat behind, together comprising a further 40%.

From January 2021 to December 2021, the most notable rate of growth in terms of shipments, amongst the main countries of destination, was attained by Bangladesh (with a CAGR of +183.6%), while the other leaders experienced more modest paces of growth.

In value terms, Pakistan ($265M), the Philippines ($263M) and Indonesia ($215M) appeared to be the largest markets for vaccines exported from the United States worldwide, together accounting for 31% of total exports. These countries were followed by Brazil, Bangladesh, Belgium, Vietnam, Mexico, Nigeria, Peru, Chile, the Netherlands and France, which together accounted for a further 31%.

Bangladesh, with a CAGR of +223.9%, saw the highest rates of growth with regard to the value of exports, among the main countries of destination over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Source: IndexBox Market Intelligence Platform

This report provides an in-depth analysis of the vaccine market in the U.S.. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

  • Prodcom 21202140 -
  • Prodcom 21202145 - Vaccines for human medicine

Country coverage:

  • United States

Data coverage:

  • Market volume and value
  • Per Capita consumption
  • Forecast of the market dynamics in the medium term
  • Trade (exports and imports) in the U.S.
  • Export and import prices
  • Market trends, drivers and restraints
  • Key market players and their profiles

Reasons to buy this report:

  • Take advantage of the latest data
  • Find deeper insights into current market developments
  • Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

  1. How to diversify your business and benefit from new market opportunities
  2. How to load your idle production capacity
  3. How to boost your sales on overseas markets
  4. How to increase your profit margins
  5. How to make your supply chain more sustainable
  6. How to reduce your production and supply chain costs
  7. How to outsource production to other countries
  8. How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

  1. 1. INTRODUCTION

    Making Data-Driven Decisions to Grow Your Business

    1. REPORT DESCRIPTION
    2. RESEARCH METHODOLOGY AND AI PLATFORM
    3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
    4. GLOSSARY AND SPECIFIC TERMS
  2. 2. EXECUTIVE SUMMARY

    A Quick Overview of Market Performance

    1. KEY FINDINGS
    2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
  3. 3. MARKET OVERVIEW

    Understanding the Current State of The Market and Its Prospects

    1. MARKET SIZE
    2. MARKET STRUCTURE
    3. TRADE BALANCE
    4. PER CAPITA CONSUMPTION
    5. MARKET FORECAST TO 2030
  4. 4. MOST PROMISING PRODUCT

    Finding New Products to Diversify Your Business

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
    2. BEST-SELLING PRODUCTS
    3. MOST CONSUMED PRODUCT
    4. MOST TRADED PRODUCT
    5. MOST PROFITABLE PRODUCT FOR EXPORT
  5. 5. MOST PROMISING SUPPLYING COUNTRIES

    Choosing the Best Countries to Establish Your Sustainable Supply Chain

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
    2. TOP PRODUCING COUNTRIES
    3. TOP EXPORTING COUNTRIES
    4. LOW-COST EXPORTING COUNTRIES
  6. 6. MOST PROMISING OVERSEAS MARKETS

    Choosing the Best Countries to Boost Your Exports

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
    2. TOP CONSUMING MARKETS
    3. UNSATURATED MARKETS
    4. TOP IMPORTING MARKETS
    5. MOST PROFITABLE MARKETS
  7. 7. PRODUCTION

    The Latest Trends and Insights into The Industry

    1. PRODUCTION VOLUME AND VALUE
  8. 8. IMPORTS

    The Largest Import Supplying Countries

    1. IMPORTS FROM 2012–2024
    2. IMPORTS BY COUNTRY
    3. IMPORT PRICES BY COUNTRY
  9. 9. EXPORTS

    The Largest Destinations for Exports

    1. EXPORTS FROM 2012–2024
    2. EXPORTS BY COUNTRY
    3. EXPORT PRICES BY COUNTRY
  10. 10. PROFILES OF MAJOR PRODUCERS

    The Largest Producers on The Market and Their Profiles

    This Chapter is Available Only for the Professional Edition PRO
  11. LIST OF TABLES

    1. Key Findings In 2024
    2. Market Volume, In Physical Terms, 2012–2024
    3. Market Value, 2012–2024
    4. Per Capita Consumption In 2012-2024
    5. Imports, In Physical Terms, By Country, 2012–2024
    6. Imports, In Value Terms, By Country, 2012–2024
    7. Import Prices, By Country Of Origin, 2012–2024
    8. Exports, In Physical Terms, By Country, 2012–2024
    9. Exports, In Value Terms, By Country, 2012–2024
    10. Export Prices, By Country Of Destination, 2012–2024
  12. LIST OF FIGURES

    1. Market Volume, In Physical Terms, 2012–2024
    2. Market Value, 2012–2024
    3. Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2024
    4. Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2024
    5. Trade Balance, In Physical Terms, 2012-2024
    6. Trade Balance, In Value Terms, 2012-2024
    7. Per Capita Consumption, 2012-2024
    8. Market Volume Forecast to 2030
    9. Market Value Forecast to 2030
    10. Products: Market Size And Growth, By Type
    11. Products: Average Per Capita Consumption, By Type
    12. Products: Exports And Growth, By Type
    13. Products: Export Prices And Growth, By Type
    14. Production Volume And Growth
    15. Exports And Growth
    16. Export Prices And Growth
    17. Market Size And Growth
    18. Per Capita Consumption
    19. Imports And Growth
    20. Import Prices
    21. Production, In Physical Terms, 2012–2024
    22. Production, In Value Terms, 2012–2024
    23. Imports, In Physical Terms, 2012–2024
    24. Imports, In Value Terms, 2012–2024
    25. Imports, In Physical Terms, By Country, 2024
    26. Imports, In Physical Terms, By Country, 2012–2024
    27. Imports, In Value Terms, By Country, 2012–2024
    28. Import Prices, By Country Of Origin, 2012–2024
    29. Exports, In Physical Terms, 2012–2024
    30. Exports, In Value Terms, 2012–2024
    31. Exports, In Physical Terms, By Country, 2024
    32. Exports, In Physical Terms, By Country, 2012–2024
    33. Exports, In Value Terms, By Country, 2012–2024
    34. Export Prices, By Country Of Destination, 2012–2024
Store
Blog
Event
U.S. - Vaccines For Human Medicine - Market Analysis, Forecast, Size, Trends and Insights
$599
Apr 1, 2025
Eye 465

This report provides an in-depth analysis of the vaccine market in the U.S..

U.S. - Antisera And Other Blood Fractions - Market Analysis, Forecast, Size, Trends and Insights
$599
Apr 1, 2025
Eye 438

This report provides an in-depth analysis of the antisera market in the U.S..

U.S. - Biological Products - Market Analysis, Forecast, Size, Trends And Insights
$599
Apr 1, 2025
Eye 535

This report provides an in-depth analysis of the biological product market in the U.S..

U.S. - Vaccines For Veterinary Medicine - Market Analysis, Forecast, Size, Trends And Insights
$599
Apr 1, 2025
Eye 331

This report provides an in-depth analysis of the veterinary medicine vaccines market in the U.S..

U.S. - Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses - Market Analysis, Forecast, Size, Trends And Insights
$599
Apr 1, 2025
Eye 390

This report provides an in-depth analysis of the market for human and animal blood in the U.S..

World - Vaccines For Human Medicine - Market Analysis, Forecast, Size, Trends and Insights
$599
Apr 1, 2025
Eye 2592

This report provides an in-depth analysis of the global vaccine market.

World - Antisera And Other Blood Fractions - Market Analysis, Forecast, Size, Trends and Insights
$599
Apr 1, 2025
Eye 1982

This report provides an in-depth analysis of the global antisera market.

World - Biological Products - Market Analysis, Forecast, Size, Trends And Insights
$599
Apr 1, 2025
Eye 427

This report provides an in-depth analysis of the global biological product market.

World - Vaccines For Veterinary Medicine - Market Analysis, Forecast, Size, Trends And Insights
$599
Apr 1, 2025
Eye 645

This report provides an in-depth analysis of the global veterinary medicine vaccines market.

World - Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses - Market Analysis, Forecast, Size, Trends And Insights
$599
Apr 1, 2025
Eye 496

This report provides an in-depth analysis of the global market for human and animal blood.

Experts Predict Smaller Winter COVID Wave in U.S., Impacting Pfizer's Growth
Feb 3, 2025
Eye 117

U.S. experts predict a smaller winter COVID wave, posing challenges for Pfizer amid declining revenues, emphasizing the need to diversify non-COVID products.

Moderna's Norovirus Vaccine Trial Advances Amid Surge in U.S. Cases
Jan 23, 2025
Eye 243

Explore Moderna's ongoing phase three norovirus vaccine trial targeting urgent prevention needs amid rising outbreaks in the U.S.

Moderna Secures an Additional $590 Million for Influenza Vaccine Development
Jan 18, 2025
Eye 210

Moderna has secured $590 million to enhance pandemic influenza vaccine development, focusing on mRNA technology and expanding human trials.

Moderna Shares Surge Amid H5N1 Vaccine Development
Jan 7, 2025
Eye 94

Moderna's shares increased by over 10% due to progress in H5N1 vaccine development following a human fatality in the U.S.

Haleon Invests $54 Million in U.S. R&D Centre for Product Innovation
Jan 29, 2025
Eye 116

Haleon invests $54M in its U.S. R&D centre to drive innovation in consumer healthcare, enhancing its product pipeline and maintaining competitive edge.

Biological Product Market in the U.S. to Post Solid Gains Amid the COVID Pandemic
Jul 10, 2020
Eye 598

For the seventh year in a row, the U.S. biological product market recorded growth in sales value, which increased by...

United States Sees Significant Drop in Human and Animal Blood Exports, Slashing Value to $3.5 Billion by 2024
Feb 10, 2025
Eye 68

In the period of 2018 to 2024, the growth of exports for Human And Animal Blood failed to regain momentum. The value of exports declined to $3.5B in 2024.

Blood Export in United States Sees Drastic Decrease to $71M in December 2023
Mar 4, 2024
Eye 1359

From February 2023 to December 2023, the exports of Human And Animal Blood saw a significant decline, dropping to $71M in value.

Moderna Revises 2025 Sales Forecast Amid Weak Vaccine Demand
Jan 13, 2025
Eye 106

Moderna cuts 2025 sales forecast by $1 billion due to weak RSV and COVID-19 vaccine demand, prompting strategic shifts and cost reductions.

The Largest Import Markets for Vaccines: Key Statistics and Trends
Sep 2, 2024
Eye 166

Explore the top import markets for vaccines and discover key statistics on their import values. Learn about the growing global demand for vaccines and the role of key countries in meeting vaccination needs.

Free Data: Vaccines For Human Medicine - United States